Is a complete VCRE research report available?

No complete published report is available for Vicore Pharma Holding AB (publ) (VCRE) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Vicore Pharma Holding AB (publ) (VCRE)

NASDAQ: VCRE · USD

$11.4

-0.01 (-0.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first VCRE analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	325.7M
Revenue (ttm)	370.6K
Net income (ttm)	-49.9M
EPS (ttm)	-$0.20
Shares out	281.5M
Volume	2,114.318
Beta	0.15

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 370.6K
Net income (ttm): -49.9M
EPS (ttm): -$0.20
Market cap: 325.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All VCRE indicators

Market & fundamental data

Available fields

152

Groups with data

Currency

SEK

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002124403
Company name	Vicore Pharma Holding AB (publ)
Country	Sweden
Country code	US
Cusip	92581R104
Employees	40
Employees Change	3%
Employees Change Percent	8.11
Enterprise value	$216.4M
Exchange	NASDAQ
Financial currency	SEK
First seen	2026-07-12
Industry	Biotechnology
Isin	US92581R1041
Last refreshed	2026-07-27
Market cap	$325.7M
Market cap category	Small-Cap
Price	$11.38
Price currency	USD
Rev Per Employee	9,265.23x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Symbol	VCRE
Website	https://www.vicorepharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-15.31%
EV Sales Forward	134.58x
EV/Sales	583.9x
FCF yield	-12.87%
P/B ratio	3.13x
P/S ratio	878.73x
PS Forward	202.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$370,609
Gross Profit Growth	-41.17%
Gross Profit Growth Q	-32.51%
Net Income	$-49.9M
Net Income Growth Years	0%
Pretax Margin	-13,452.49%
Profit Per Employee	$-1.2M
ROA	-28.12
Roa5y	-34.77
ROCE	-48.96
ROE	-47.19
Roe5y	-62.78
ROIC	-30.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	0
Revenue Growth	-41.17x
Revenue Growth Q	-32.51x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$113.2M
Cash	$111.4M
Current Assets	$110.5M
Current Liabilities	$8.7M
Debt	$0
Equity	$104.1M
Liabilities	$9.1M
Long Term Assets	$2.7M
Long Term Liabilities	$362,613
Net Cash	$111.4M
Net Cash By Market Cap	$34.19
Net Cash Growth	1.05%
Net Debt Equity	$-1.07
Tangible Book Value	$104.1M
Tangible Book Value Per Share	$0.37
WACC	5.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.69
Net Working Capital	$-7.4M
Quick ratio	12.57
Working Capital	$104M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-50.17%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	17.8
All Time High Change	-36.07%
All Time High Date	2026-07-07
All Time Low	11
All Time Low Change	3.45%
All Time Low Date	2026-07-23
ATR	1.14
Beta	0.15
High	11.42
High52	17.8
High52 Date	2026-07-07
High52ch	-36.07%
Low	11.38
Low52	11
Low52 Date	2026-07-23
Low52ch	3.46%
Premarket Change Percent	1.49
Premarket Price	$11.56
Premarket Volume	213
RSI	6.11
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	-12.91x
Sortino ratio	-10.09
Total Return	-50.17%
Tr1w	-3.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-51.1M
Operating margin	-13,779.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	198,621,158%
Float Percent	70.55%
Shares Insiders	4.88%
Shares Institutions	33.38%
Shares Out	281,525,593
Shares Qo Q	10.07%
Shares Yo Y	50.17%
Short Float	0.01%
Short Ratio	0.15
Short Shares	0.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-41.9M
Average Volume	59,432.87x
Bv Per Share	0.37
Ch1w	-3.72
Change	-0.09%
Change From Open	-0.35
Close	11.39
Days Gap	0.26
Dollar Volume	24,060.9
Earnings Date	2026-08-21
EBIT	$-51.1M
EPS	$-0.2
F Score	1
FCF	$-41.9M
FCF EV Yield	-19.36x
FCF Per Share	$-0.15
Financing CF	45,240,607
Fiscal Year End	December
Founded	2,000
Income Tax	$9,037
Investing CF	-37,336,552
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Net CF	-35,521,438
Next Earnings Date	2026-08-21
Open	11.42
Position In Range	0
Post Close	11.38
Postmarket Change Percent	5.45
Postmarket Price	$12
Pre Close	11.39
Price Date	2026-07-24
Ptbv Ratio	3.13
Relative Volume	0.04x
Revenue	370,609x
Tax By Revenue	2.44x
Volume	2,114.3

Vicore Pharma Holding AB (publ) (VCRE)

Coverage state: Market snapshot only — no published research

Generate the first VCRE analysis

Price

Financial snapshot

Fair-value bridge

Latest news · VCRE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VCRE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on VCRE

Frequently asked questions